The phenotypic studies of tumor-infiltrating Treg in relation to CD39 expression were partly based on the immunosuppressive surface molecules analyzed; ICOS, PD-L1 and CTLA-4, which were all increased on CD39+ Treg. This evidence concerns the gene CD274 and neoplasm.